Detalhe da pesquisa
1.
Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study.
BMC Endocr Disord
; 23(1): 160, 2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507703
2.
Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes.
Int J Equity Health
; 19(1): 221, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33302956
3.
Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.
BMC Infect Dis
; 19(1): 41, 2019 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630429
4.
Design and rationale of the Botswana Smoking Abstinence Reinforcement Trial: a protocol for a stepped-wedge cluster randomized trial.
Implement Sci Commun
; 5(1): 53, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720363
5.
Prevalence and Risk Factors for Mycobacterium tuberculosis Infection among Health Workers in HIV Treatment Centers in North Central, Nigeria.
Am J Trop Med Hyg
; 109(1): 60-68, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253444
6.
Factors associated with receipt of a timely infant birth dose of hepatitis B vaccine at a tertiary hospital in North-Central Nigeria.
PLOS Glob Public Health
; 2(9): e0001052, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962881
7.
Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
PLoS One
; 16(10): e0259492, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710200
8.
A systematic review and meta-analysis of the prevalence of hepatitis B virus infection among pregnant women in Nigeria.
PLoS One
; 16(10): e0259218, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714888
9.
Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
PLoS One
; 15(12): e0241065, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259492
10.
Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.
World J Virol
; 4(2): 105-12, 2015 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964875